AMPK homologs from all eukaryotes contain an "N-isoamylase" domain, which is located between residues 72 and 151 in rat ␤1. These noncatalytic domains are found in a variety of other proteins, most of which are enzymes that metabolize the ␣1→6 branches in ␣1→4 are not apparently affected by the absence of the GBD. using truncated ␤ subunits lacking the GBD. Our reTo confirm that the N-terminally truncated ␤ subunits sults suggest that the GBD binds glycogen and can lacking the GBD/KIS domain still formed a heterotrimeric lead to abnormal glycogen-containing inclusions ␣␤␥ complex, myc-tagged ␣1 was coexpressed with ␥1 when the kinase is overexpressed. These may be reand various truncated ␤1 constructs in cells incubated lated to the abnormal glycogen storage bodies seen with . However, in that case, the ␥ subunit gene (SNF4) had been deleted, and it is possible that in immunoprecipitates irrespective of whether the expressed ␤ subunit contained the GBD. They were also in our studies the ␥ subunit was bridging ␣ and ␤ to form the complex. Our data do not rule out the possibility detected with an antibody that recognizes the C terminus of ␤1. No ␤1 polypeptide was detected by 35 S labelthat regions N-terminal to the ASC domain of mammalian ␤ interact with ␣, although clearly this is not necesing or with an anti-␤1 antibody in the anti-myc immunoprecipitates from cells in which a C-terminally sary to form a stable, active complex. We also coexpressed plasmids encoding green fluotruncated (64-257) or no exogenous ␤ subunit had been expressed (note that C-terminal truncation might affect rescent protein-(GFP-) or myc-tagged ␣1 with fulllength ␤1 or ␤2 and ␥1 in CCL13 cells. By using isorecognition by this antibody).
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These results show that the GBD is not necessary for form-specific antibodies, we found that all expressed subunits and subunit fusions migrated with the expected 270). However, with constructs lacking either part or all of the GDB/KIS domain (113-270, 167-170, and 196-size; moreover, in every case, there was a modest increase in kinase activity, ranging from 1.6-fold to 5.3-270), no cells containing inclusions were observed, even though several hundred cells expressing GFP were exfold, over the endogenous level ( Figure S1 ). Cells expressing GFP-tagged ␣ subunits with ␤ and ␥ were amined. Thus, the GBD is essential for the formation of the inclusions. With either ␤1 or ␤2, the frequency of examined in a wide-field deconvolution microscope. In a significant proportion of cells, we observed striking transfected cells containing inclusions was not dependent on the kinase activity of the complex. Thus, essenfluorescent inclusions of ovoid shape in the cytoplasm (Figures 3 and 4, green color) . These were more frequent tially the same frequency was obtained with wild-type GFP-␣1 (␤1: 26% Ϯ 11%, n ϭ 34 fields; ␤2, 70% Ϯ 13%, when ␤2 was overexpressed (70% Ϯ 13% of transfected cells, mean Ϯ SD for n ϭ 34 fields, or 342/484 cells) n ϭ 34), with a T172D mutant that activates the kinase by mimicking phosphorylation (␤1: 24% Ϯ 11%, n ϭ 36; rather than ␤1 (26% Ϯ 11%, n ϭ 34, 146/546 cells). In cells expressing ␤2, there were 2-16 inclusions per cell, ␤2, 61% Ϯ 14%, n ϭ 35), or with a D139A/T172D mutant that removes an aspartic acid essential for kinase activwith a mean number of 7 Ϯ 4 (n ϭ 20), varying in length from 0.5 to 5 m (mean ϭ 1.5 Ϯ 0.9, n ϭ 139). In cells ity (␤1: 16% Ϯ 7%, n ϭ 35; ␤2, 64% Ϯ 13%, n ϭ 31). Immunoprecipitate kinase assays confirmed that the acexpressing ␤1, there were also 2-16 inclusions per cell (mean ϭ 6 Ϯ 3, n ϭ 23) that varied from 0.4 to 5 m in tivities of the T172D mutants were higher than the wildtype (␤1, 6.2 Ϯ 0.5-fold, n ϭ 2; ␤2, 5.7 Ϯ 0.7-fold, n ϭ length (mean ϭ 1.7 Ϯ 1.2, n ϭ 90). Identical inclusions were observed when we coexpressed the ␤ subunits 2), while the D139A/T172D mutants were completely inactive. with GFP-␣2 rather than GFP-␣1, or with ␥2 or ␥3 rather than ␥1 (not shown). They were not an artifact of the Because the GBD was essential for the generation of these inclusions, we suspected that they might contain GFP tag, because they were also observed when myctagged ␣1 subunits were expressed and detected with glycogen. We therefore utilized a monoclonal antibody that recognizes glycogen. Figure 3 shows that the incluanti-myc antibodies.
Identical frequencies of inclusions were observed by sions stained with this antibody (red color) and that staining was much stronger when ␤2 rather than ␤1 was using full-length (26% Ϯ 11%) or truncated (27% Ϯ 12%) ␤1 constructs that still contained the entire GBD (64-expressed. Staining was not observed if the permeabil- ized cells were pretreated with ␣-amylase (not shown); were observed more frequently in cells expressing ␤2 (70%) than ␤1 (26%) is that CCL13 cells do not appear this finding confirms that the antibody was detecting glycogen. Close inspection of the inclusions at high to express endogenous ␤2 ( Figure S1 ). These cells may therefore not express appropriate anchoring proteins, magnification (Figure 3, insets) revealed that the GFP fluorescence and the glycogen staining were granular leading to a higher tendency to form aggregates when ␤2 complexes are overexpressed. in appearance and did not completely overlap. Since glycogen synthase colocalizes with glycogen [12], we
The boundaries of the KIS domain were not precisely mapped in the yeast two-hybrid study [9] , and the only also utilized an anti-glycogen synthase antibody ( Figure  4) . Although this antibody (unlike the anti-glycogen antiportion that is highly conserved across all species corresponds to the GBD. Given that closely related domains body) gave a general "speckled" cytoplasmic staining, particularly in cells expressing ␤2 (Figure 4E) , the signal are found in enzymes that bind and metabolise ␣1→6 branched glucans, that this domain is not necessary for was highly enriched in the inclusions.
The cytoplasmic inclusions could also be observed by complex formation but is essential for the formation of unusual glycogen storage bodies when AMPK is overexdifferential interference contrast microscopy, but they were only apparent in transfected (fluorescent) cells, not pressed (this paper), and that results in a companion paper [14] show that the isolated GBD binds glycogen in nontransfected cells in the same field. Cryo-immuno-EM with gold-labeled anti-GFP antibodies revealed that in cell-free assays, we propose that, in the future, the term KIS (kinase interaction sequence) should be abanthe inclusions appeared as patches of higher electron density in the cytoplasm. Although membranes were doned and that the term glycogen binding domain should be used instead. clearly visible in the cells, the inclusions were not membrane limited ( Figure S2) .
What is the normal, physiological function of the GBD? Firstly, glycogen synthase is phosphorylated and inactiGlycogen particles studied by conventional osmium/ heavy metal-staining EM techniques appear as " 
